Genomic identification of potential targets unique to Candida albicans for the discovery of antifungal agents

Current Drug Targets

Volumn 15, Issue 1, 2014, Pages 136-149

  Tripathi, Himanshu ^a   Luqman, Suaib ^a   Meena, Abha ^a   Khan, Feroz ^a  

^a CSIR CENTRAL INSTITUTE OF MEDICINAL AND AROMATIC PLANTS   (India)

Author keywords

Antifungal agents; Candida albicans; Comparative genomics; Drugs; Proteome; Targets

Indexed keywords

ALLYLAMINE; ANTIFUNGAL AGENT; CANDIDA ALBICANS EXTRACT; ECHINOCANDIN; PHOSPHORIBOSYLTRANSFERASE; POLYENE; PYRIMIDINE; PYRROLE; SQUALENE MONOOXYGENASE; STEROL 14ALPHA DEMETHYLASE; TRANSCRIPTION FACTOR; 1,3 BETA GLUCAN SYNTHASE; CELL MEMBRANE PROTEIN; PURINE NUCLEOSIDE PHOSPHORYLASE;

AMINO ACID SEQUENCE; ARTICLE; ASPERGILLUS FUMIGATUS; BIOLOGICAL PHENOMENA AND FUNCTIONS CONCERNING THE ENTIRE ORGANISM; CANDIDA ALBICANS; CELLULAR DISTRIBUTION; CRYPTOCOCCUS NEOFORMANS; CRYSTALLOGRAPHY; GENE IDENTIFICATION; GENE MUTATION; GENE ONTOLOGY; GENOMICS; HUMAN; MOLECULAR INTERACTION; NONHUMAN; PROTEIN ANALYSIS; SACCHAROMYCES CEREVISIAE; CARBON UTILIZATION; CELL ADHESION; GENE SEQUENCE; GENETIC IDENTIFICATION; PROTEIN EXPRESSION; PROTEOMICS; SEX DIFFERENCE;

ANTIFUNGAL AGENTS; CANDIDA ALBICANS; DRUG DISCOVERY; DRUG RESISTANCE, MICROBIAL; FUNGAL PROTEINS; GENOME, FUNGAL; HUMANS; MICROBIAL SENSITIVITY TESTS; SEQUENCE HOMOLOGY, AMINO ACID; TRANSCRIPTION FACTORS;

EID: 84892981925     PISSN: 13894501     EISSN: 18735592     Source Type: Journal    
DOI: 10.2174/138945011501140115112242     Document Type: Article

References (21)

1. Lai CC, Tan CK, Huang YT, Shao PL, Hsueh PR. Current challenges in the management of invasive fungal infections. J Infect Chemother 2008; 14: 77-85.
2. Park BJ, Wannemuehler KA, Marston BJ, Govender N, Pappas PG, Chiller TM. Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS. AIDS 2009; 23: 525-30.
3. Butts A, Krysan DJ. Antifungal Drug Discovery: Something Old and Something New. PLoS Pathog 2012; 8(9): e1002870.
4. Georgopapadakou NH, Walsh TJ. Human mycoses: drugs and targets for emerging pathogens. Science 1994; 264: 371-3.
5. Georgopapadakou NH, Walsh TJ. Antifungal agents: Chemotherapeutic targets and immunologic strategies. Antimicrob Agents Chemother 1996; 40 (2): 279-91.
6. Georgopapadakou NH. Antifungal: mechanism of action and resistance, established and novel dongs. Curr Opin Microbiol 1998; 1: 547-57.
7. Sterling TR, Merz WG. Resistance to amphotericin B: emerging clinical and microbiological patterns. Drug Resist Updat 1998; 1: 161-5.
8. Sanglard D, Ischer F, Parkinson T, Falconer D, Bille J. Candida albicans mutations in ergosterol biosynthetic pathway and resistance to several antifungal agents. Antimicrob. Agents Chemother 2003; 47(8): 2404-12.
9. Bodey GP. Candidiasis in cancer patients. In: Bodey GP: Candidiasis: a growing concern. Am J Med 1984; 77(4D): 13-9.
10. Bodey GP, Mardani M, Hanna HA, et al. The epidemiology of Candida glabrata and Candida albicans fungemia in immunocompromised patents with Cancer. Am J Medicine 2002; 112: 380-385.
11. Odds FC. Resistance of yeasts to azole-derivative antifungals. J Antimicrob Chemother 1993; 31: 463-71.
12. Rex HJ, Rinaldi MG, Pfaller MA. Resistance of Candida species to fluconazole. Antimicrob Agents Chemother 1995; 39: 1-8.
13. Nguyen MH, Peacock JE, Morris AJ. The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance. Am J Med 1996; 100: 617-23.
14. Alexander BD, Perfect JR. Antifungal Resistance Trends towards the Year 2000. Drugs 1997; 54 (4): 657-78.
15. Odds FC. Genomics, molecular targets and the discovery of antifungal drugs. Rev Iberoam Micol 2005; 22: 229-37.
16. Galperin MY, Koonin EV. Searching for drug targets in microbial genomes. Curr Opin Biotechnol 1999; 10: 571-8.
17. Jones T, Federspie NA, Chibana H, et al. The diploid genome sequence of Candida albicans. PNAS 2004; 101(19): 7329-34.
18. Altschul SF, Madden TL, Schaffer AA, et al. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res 1997; 25: 3389-402.
19. Li J, Huang S, Chen J, et al. Identification and characterization of human uracil phosphoribosyltransferase (UPRTase). J Hum Genet 2007; 52: 415-22.
20. Sangamwar AT, Deshpande UD, Pekamwar SS. Antifungals: need to search for a new molecular target. Indian J Pharm Sci 2008; 70(4): 423-30.
21. Vermes A, Guchelaar HJ, Dankert J. Flucytosine: a review of its pharmacology, clinial indications, pharmacokinectics, toxicity and drug interactions. J Antimicrob Chemother 2000; 46: 171-9.